These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 360239

  • 21. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW, Gueorguieva RV, Baker CB, Makuch RW.
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [Abstract] [Full Text] [Related]

  • 22. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY, Sommers AA, Luchins DJ.
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [Abstract] [Full Text] [Related]

  • 23. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
    Mallinger JB, Lamberti SJ.
    J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
    [Abstract] [Full Text] [Related]

  • 24. [Statistical aspects in planning psychotropic drug trials (author's transl)].
    Ferner U.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):132-9. PubMed ID: 360237
    [Abstract] [Full Text] [Related]

  • 25. Interaction of changes in hospital environment and neurotropic co-medication in chronic psychiatric inpatient. A placebo controlled double-blind study.
    Lehmann E, Kretschmar JH, Brauer H, Reinhardt B.
    Pharmacopsychiatria; 1982 Mar; 15(2):57-60. PubMed ID: 7043497
    [Abstract] [Full Text] [Related]

  • 26. Methods of evaluation of psychoactive drugs.
    Bech P.
    Recenti Prog Med; 1989 Dec; 80(12):706-11. PubMed ID: 2697905
    [Abstract] [Full Text] [Related]

  • 27. Are psychoactive-drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiatric disorders?
    Diebold K, Michel G, Schweizer J, Diebold-Dörsam M, Fiehn W, Kohl B.
    Pharmacopsychiatry; 1998 Mar; 31(2):60-7. PubMed ID: 9562210
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Use of the new psychotropic preparation bemitil in treating asthenic disorders (clinico-pharmacological research)].
    Aleksandrovskiĭ IuA, Bobkov IuG, Neznamov GG, Serebriakova TV, Boĭko SS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 Jun; 88(3):109-15. PubMed ID: 3381606
    [Abstract] [Full Text] [Related]

  • 33. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
    Grohmann R, Hippius H, Helmchen H, Rüther E, Schmidt LG.
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
    [Abstract] [Full Text] [Related]

  • 34. [Influence of treatment course on the success of psychopharmacotherapy].
    Gaebel W.
    Psychiatr Prax; 1985 Jan; 12(1):13-8. PubMed ID: 2858897
    [Abstract] [Full Text] [Related]

  • 35. The importance of non-biological factors in influencing the outcome of clinical trials.
    Gaebel W.
    Br J Psychiatry Suppl; 1993 Dec; (22):45-50. PubMed ID: 8110443
    [Abstract] [Full Text] [Related]

  • 36. [The AMDP scales in a phase II evaluation of psychotropic drugs].
    Digonnet C, Boyer P, Puech AJ, von Frenckell R, Weil JS.
    Acta Psychiatr Belg; 1987 Dec; 87(2):245-52. PubMed ID: 3618275
    [Abstract] [Full Text] [Related]

  • 37. Clinical factors that may confound the assessment of drug efficacy.
    Csernansky JG, Newcomer JW, Miller LS, Faustman WO.
    Psychopharmacol Bull; 1991 Dec; 27(3):231-5. PubMed ID: 1775593
    [Abstract] [Full Text] [Related]

  • 38. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C, Polard E, Mauduit N, Allain H.
    Encephale; 2001 Dec; 27(4):351-9. PubMed ID: 11686057
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Speed of onset.
    Leber P.
    Psychopharmacol Bull; 1995 Dec; 31(1):37-40. PubMed ID: 7675987
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.